JP2004524368A5 - - Google Patents

Download PDF

Info

Publication number
JP2004524368A5
JP2004524368A5 JP2002578922A JP2002578922A JP2004524368A5 JP 2004524368 A5 JP2004524368 A5 JP 2004524368A5 JP 2002578922 A JP2002578922 A JP 2002578922A JP 2002578922 A JP2002578922 A JP 2002578922A JP 2004524368 A5 JP2004524368 A5 JP 2004524368A5
Authority
JP
Japan
Prior art keywords
lipid
container
aqueous dispersion
dispersion
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002578922A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004524368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/003371 external-priority patent/WO2002080883A2/en
Publication of JP2004524368A publication Critical patent/JP2004524368A/ja
Publication of JP2004524368A5 publication Critical patent/JP2004524368A5/ja
Withdrawn legal-status Critical Current

Links

JP2002578922A 2001-03-27 2002-03-26 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物 Withdrawn JP2004524368A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01302841 2001-03-27
PCT/EP2002/003371 WO2002080883A2 (en) 2001-03-27 2002-03-26 Method and composition for solubilising a biologically active compound with low water solubility

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009199056A Division JP2010013461A (ja) 2001-03-27 2009-08-28 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2004524368A JP2004524368A (ja) 2004-08-12
JP2004524368A5 true JP2004524368A5 (https=) 2005-06-09

Family

ID=8181836

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002578922A Withdrawn JP2004524368A (ja) 2001-03-27 2002-03-26 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
JP2009199056A Pending JP2010013461A (ja) 2001-03-27 2009-08-28 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
JP2012163789A Pending JP2012207042A (ja) 2001-03-27 2012-07-24 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009199056A Pending JP2010013461A (ja) 2001-03-27 2009-08-28 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
JP2012163789A Pending JP2012207042A (ja) 2001-03-27 2012-07-24 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物

Country Status (11)

Country Link
US (2) US20040115255A1 (https=)
EP (1) EP1389089B1 (https=)
JP (3) JP2004524368A (https=)
AT (1) ATE440593T1 (https=)
AU (1) AU2002312777B2 (https=)
CA (1) CA2442539C (https=)
DE (1) DE60233484D1 (https=)
DK (1) DK1389089T3 (https=)
ES (1) ES2332584T3 (https=)
PT (1) PT1389089E (https=)
WO (1) WO2002080883A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444383B2 (en) 2000-06-17 2008-10-28 Microsoft Corporation Bounded-deferral policies for guiding the timing of alerting, interaction and communications using local sensory information
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6869617B2 (en) 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
DE10203923B4 (de) * 2002-01-31 2011-06-01 Klinipharm Gmbh Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung
CA2539486A1 (en) * 2003-10-02 2005-04-07 Sembiosys Genetics Inc. Methods for preparing oil bodies comprising active ingredients
WO2005065677A1 (ja) * 2004-01-09 2005-07-21 Otsuka Pharmaceutical Factory, Inc. パクリタキセルまたはドセタキセルを溶解または分散させるための脂肪乳剤
EP1748759B1 (en) * 2004-04-27 2013-03-27 Javeri, Indu Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2660172T3 (es) * 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
AU2005302255A1 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
CN101137395B (zh) * 2005-03-14 2012-10-31 株式会社大塚制药工场 含有水难溶性药物的医药组合物
JP5342834B2 (ja) * 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
EP3415151A1 (en) * 2008-05-23 2018-12-19 The University of British Columbia Modified drugs for use in liposomal nanoparticles
LT2344198T (lt) * 2008-09-27 2021-02-25 Jina Pharmaceuticals Inc. Farmaciniai preparatai lipidų pagrindu, skirti vietiniam naudojimui
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2781529C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
US20170340563A1 (en) * 2009-09-23 2017-11-30 Curirx Inc. Methods for the Preparation of Liposomes Comprising Drugs
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CN101926757B (zh) * 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
BR112013014291A2 (pt) * 2010-12-08 2016-09-20 Hoffmann La Roche formulação lipossômica de calcetrapib
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US20150157610A1 (en) * 2012-05-23 2015-06-11 Osaka University Pharmaceutical composition for treating inflammatory disease
EP2682106A1 (en) 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Method of solubilizing biologically active compounds
CA3007438C (en) 2015-12-07 2025-05-13 Elka Touitou COMPOSITIONS OF THERAPEUTIC SUBSTANCES, RELATED PROCESSES AND USES
MD3532067T2 (ro) 2016-10-28 2022-10-31 Servier Lab Formă farmaceutică lipozomală pentru utilizare în tratamentul cancerului
EP3634385A4 (en) * 2017-05-12 2021-03-03 Curinanorx, LLC LIPOSOME PREPARATION PROCESSES INCLUDING MEDICINAL PRODUCTS

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
DE3883206T3 (de) * 1987-09-07 2003-11-13 Teijin Ltd., Osaka Arzneistoff enthaltende fettemulsion des typs "kurz vor gebrauch hergestellt" sowie verfahren zur herstellung einer arzneihaltigen fettemulsion.
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
AU660288B2 (en) * 1990-07-31 1995-06-22 Transave, Inc. Accumulation of amino acids and peptides into liposomes
CA2157489A1 (en) * 1993-03-04 1994-09-15 Masaaki Numata Lewis-associated compound, process for producing the same, and anti-inflammatory
DE19609538A1 (de) * 1996-03-11 1997-09-18 Basf Ag Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung
EP0699068B1 (en) * 1993-05-21 2001-12-19 The Liposome Company, Inc. Reduction of liposome-induced adverse physiological reactions
EP0633024A1 (en) * 1993-07-09 1995-01-11 Ciba-Geigy Ag Topically administrable zinc phthalocyanine compositions
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE69503629T2 (de) * 1994-05-23 1998-11-26 B. Braun Medical Inc., Bethlehem, Pa. 18018 Vorrichtung zur herstellung einer formulierung
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6447800B2 (en) * 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
EP0974364A4 (en) * 1996-10-25 2000-12-20 Yoshitomi Pharmaceutical METHOD FOR PREVENTING THE PREPARATION OF MEDICINAL PRODUCTS
DE59710082D1 (de) * 1996-12-13 2003-06-18 Vesifact Ag Baar Kosmetische Präparate in Form einer Nanodispersion
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
WO2000002534A1 (fr) * 1998-07-10 2000-01-20 Welfide Corporation Kit a preparer avant usage avec preparation contenant un medicament et solvant destine a cette fin
DE19843968A1 (de) * 1998-09-24 2000-04-13 Hans Dietl Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung
US6682758B1 (en) * 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
EP1985285A3 (en) * 1999-04-01 2009-08-12 Hana Biosciences, Inc. Compositions and methods for treating lymphoma
US20030144570A1 (en) * 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes

Similar Documents

Publication Publication Date Title
JP2004524368A5 (https=)
EP0584315B1 (fr) Composition cosmetique et/ou pharmaceutique contenant une dispersion de vesicules lipidiques, procede de preparation de ladite dispersion et dispersion de vesicules lipidiques
JP2659136B2 (ja) 両親媒性分子を有効に充填かつ制御放出するリポソーム
Ahad et al. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment
CN110433089B (zh) 用于促进皮肤吸收的囊泡以及其制备方法
FR2988609A1 (fr) Formulation pour l'hormonotherapie
CN110545796A (zh) 用于活性化合物的局部递送系统
WO2004080381A2 (fr) Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
JP2011509074A5 (https=)
JPH054037A (ja) 安定なリポソーム水懸濁液
JP2012207042A (ja) 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
Ng et al. Chlorosome-inspired synthesis of templated metallochlorin-lipid nanoassemblies for biomedical applications
ITMI20090350A1 (it) Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
JPS63116737A (ja) 一様な二重層化されたリポソームの製造法
AU698915B2 (en) Ketoprofen liposomes
CN110151992A (zh) 一种包载染料j聚集体的复合纳米胶束及其制备方法和应用
EP2407158A1 (en) Ph-responsive liposome
JP2000143510A (ja) 外用組成物
Upadhye et al. Proniosomes: A novel vesicular drug delivery system
JP3187622B2 (ja) リポソーム
JP2000319170A (ja) テプレノン含有点眼剤
US20070031485A1 (en) Pharmaceutical composition having a cationic excipient
EP2255790B1 (en) Liposome composition comprising naproxen, and a method of obtaining same
CN108236604A (zh) 阿哌沙班柔性脂质体
US20140017302A1 (en) Optimised preparations of highly adaptable aggregates